Who
Michael Mano
EVP, CLO&Secretary
Company insider
Files Form 4 as: EVP, CLO&Secretary, Karyopharm Therapeutics.
In numbers
- Trades disclosed
- 28
- Buys
- 0
- Sells
- 9
- Bought
- $0
- Sold
- $144K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Feb 2022
- Last trade
- 14 May 2026
- Last filed
- 15 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,527266 at $9.50 | filing |
| 14 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,527266 at $9.50 | filing |
| 13 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —700 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —700 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $33K3,526 at $9.41 | filing |
| 2 Mar 2026filed 3 Mar 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $33K3,526 at $9.41 | filing |
| 31 Jan 2026filed 3 Feb 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —32,415 at $0.00 | filing |
| 31 Jan 2026filed 3 Feb 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —32,415 at $0.00 | filing |
| 15 Oct 2025filed 16 Oct 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —43,650 at $0.00 | filing |
| 15 Sep 2025filed 16 Sep 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,505234 at $6.43 | filing |
| 12 Sep 2025filed 16 Sep 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —612 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $18K2,793 at $6.29 | filing |
| 28 Feb 2025filed 4 Mar 2025 | KPTI Karyopharm Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,666 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | KPTI Karyopharm Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,500 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —3,333 at $0.00 | filing |
| 28 Feb 2025filed 4 Mar 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —2,250 at $0.00 | filing |
| 4 Sep 2024filed 5 Sep 2024 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,8593,971 at $0.72 | filing |
| 1 Mar 2024filed 4 Mar 2024 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $4,2913,576 at $1.20 | filing |
| 29 Feb 2024filed 4 Mar 2024 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $20K16,973 at $1.17 | filing |
| 28 Feb 2024filed 29 Feb 2024 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —147,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.